16.16

6.21% -1.07

After Hours: 16.38 0.22 +1.36%

Igm Biosciences Inc (IGMS)

Overview News Price History Option Chain Financials Discussions Forecast

Igm Biosciences Inc stock is traded at $16.16, with a volume of 545.19K. It is down -6.21% in the last 24 hours and up +62.58% over the past month. IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.

Previous Close:

$17.23

Open:

$17.3

24h Volume:

545.19K

Relative Volume:

1.75

Market Cap:

$968.08M

Revenue:

$2.91M

Net Income/Loss:

$-220.40M

P/E Ratio:

-3.0664

EPS:

-5.27

Net Cash Flow:

$-176.15M

1W Performance:

+31.38%

1M Performance:

+62.58%

6M Performance:

+63.89%

1Y Performance:

+131.85%

1-Day Range:

$15.70

$17.30

1-Week Range:

$12.35

$22.50

52-Week Range:

$3.81

$22.50

Igm Biosciences Inc Stock (IGMS) Company Profile

Name

Igm Biosciences Inc

Sector

Healthcare (1186)

Industry

Biotechnology (678)

Phone

650-965-7873

Address

325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW

Employee

204

Twitter

Next Earnings Date

2024-08-26

Latest SEC Filings

IGMS's Discussions on Twitter

Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-09-22	Resumed	Jefferies	Buy
Oct-17-22	Initiated	JP Morgan	Neutral
Aug-29-22	Initiated	BofA Securities	Buy
Dec-13-21	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-05-21	Upgrade	Wedbush	Neutral → Outperform
Aug-26-21	Initiated	Morgan Stanley	Overweight
Jan-29-21	Initiated	RBC Capital Mkts	Outperform
Jan-19-21	Reiterated	H.C. Wainwright	Buy
Dec-22-20	Downgrade	Wedbush	Outperform → Neutral
Jul-17-20	Initiated	Robert W. Baird	Outperform
Jul-01-20	Initiated	H.C. Wainwright	Buy
May-28-20	Initiated	SunTrust	Buy
Apr-22-20	Initiated	Wedbush	Outperform
Oct-14-19	Initiated	Guggenheim	Buy
Oct-14-19	Initiated	Jefferies	Buy
Oct-14-19	Initiated	Piper Jaffray	Overweight
Oct-14-19	Initiated	Stifel	Buy

View All

Igm Biosciences Inc Stock (IGMS) Latest News

04:44 AM

Learn to Evaluate (IGMS) using the Charts - Stock Traders Daily

04:44 AM

Sep 19, 2024

why ImmunityBio Inc [IBRX] is a Good Choice for Investors After New Price Target of $6.38 - The DBT News

Sep 19, 2024

IGM Financial (TSE:IGM) Hits New 1-Year High at $40.00 - MarketBeat

Sep 19, 2024

Ipsy names CEO - Retail Dive

Sep 19, 2024

Misbah Tahir Sells 1,487 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stock - Defense World

Sep 19, 2024

Ipsy Appoints Galen C. Smith As CEO - Beauty Packaging

Sep 19, 2024

Fred Schwarzer Sells 3,946 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stock - Defense World

Sep 19, 2024

ImmunityBio, Inc. (NASDAQ:IBRX) Shares Purchased by Private Advisor Group LLC - Defense World

Sep 19, 2024

IGG (OTCMKTS:IGGGF) Shares Up 46.9% - Defense World

Sep 19, 2024

IGM Biosciences (NASDAQ:IGMS) Trading Down 4.1% on Insider Selling - Defense World

Sep 19, 2024

Sep 18, 2024

Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move - Benzinga

Sep 18, 2024

IGM Biosciences (NASDAQ:IGMS) Stock Price Down 4.1% on Insider Selling - MarketBeat

Sep 18, 2024

IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains? - Yahoo Finance

Sep 18, 2024

What was IGM Biosciences Inc (IGMS)’s performance in the last session? - US Post News

Sep 18, 2024

IBRX Stock on the Rise: A Promising Investment - The InvestChronicle

Sep 18, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) Shares Bought by Quest Partners LLC - Defense World

Sep 18, 2024

Sep 17, 2024

IGM Biosciences CFO sells over $17k in company stock By Investing.com - Investing.com Canada

Sep 17, 2024

IGM Biosciences CFO sells over $17k in company stock - Investing.com

Sep 17, 2024

IGM Biosciences chief scientific officer sells $17k in stock By Investing.com - Investing.com Canada

Sep 17, 2024

IGM Biosciences chief scientific officer sells $17k in stock - Investing.com

Sep 17, 2024

IGM Biosciences executive sells over $17k in company stock - Investing.com

Sep 17, 2024

IGM Biosciences (NASDAQ:IGMS) Sets New 12-Month High at $18.34 - MarketBeat

Sep 17, 2024